Page 163 - Orange Book Cumulative Supplement 10 October 2012

A - 26
PATENT & EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 10 - October 2012
See List footnote for information regarding List content

PATENT PATENT EXCLUSIVITY
EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION
APPL/PROD DATE REQUESTED DATE
NO PATENT NO CODES CODE(S)
LEVOCETIRIZINE DIHYDROCHLORIDE - XYZAL
N022157 001 5698558 Jul 26, 2013 U-852
5698558*PED Jan 26, 2014
LIDOCAINE; TETRACAINE - SYNERA
N021623 001 6465709 Jul 07, 2020 DP

LINACLOTIDE - LINZESS
N202811 001 7304036 Jan 28, 2024 DS DP U-1278 NCE Aug 30, 2017
7371727 Jan 28, 2024 DS
7704947 Jan 28, 2024 DS DP
7745409 Jan 28, 2024 DS DP
8080526 Jan 28, 2024 DS DP
8110553 Jan 28, 2024 U-1278
LINACLOTIDE - LINZESS
N202811 002 7304036 Jan 28, 2024 DS DP U-1278 NCE Aug 30, 2017
7371727 Jan 28, 2024 DS
7704947 Jan 28, 2024 DS DP
7745409 Jan 28, 2024 DS DP
8080526 Jan 28, 2024 DS DP
8110553 Jan 28, 2024 U-1278
LINAGLIPTIN - TRADJENTA
N201280 001 6303661 Apr 24, 2017 U-774 M-121 Aug 13, 2015
6303661 Apr 24, 2017 U-1270 M-118 Aug 13, 2015
6890898 Feb 02, 2019 U-493
6890898 Feb 02, 2019 U-1270
7078381 Feb 02, 2019 U-493
7078381 Feb 02, 2019 U-1270
7459428 Feb 02, 2019 U-493
7459428 Feb 02, 2019 U-1270
8119648 Aug 12, 2023 U-774
8119648 Aug 12, 2023 U-1270
8178541 Aug 12, 2023 U-775
8178541 Aug 12, 2023 U-1270
8178541 Aug 12, 2023 U-1245
8178541 Aug 12, 2023 U-1244
LINAGLIPTIN; METFORMIN HYDROCHLORIDE - JENTADUETO
N201281 001 6303661 Apr 24, 2017 U-802 NCE May 02, 2016
6890898 Feb 02, 2019 U-1039 NC Jan 30, 2015
7078381 Feb 02, 2019 U-1039
7407955 Aug 12, 2023 DS DP
7459428 Feb 02, 2019 U-1039
8119648 Aug 12, 2023 U-802
8178541 Aug 12, 2023 DP U-775